Navigation Links
Lilly Reports Solid Second-Quarter Results
Date:7/24/2008

71 40% to 45%

Asset impairments and

restructuring charges (included

in asset impairments restructuring

and other special charges) .14 .15

Asset impairments (included in .04 -

cost of sales)

Charge for a reduction in expected

insurance recoveries - .06

In-process research and development

charges associated with ICOS,

Hypnion, and Ivy acquisitions

(2007) and in-licensing

transactions with BioMS and

TransPharma (2008) and OSI,

MacroGenics and Glenmark (2007) .07 .63

Benefit from resolution of IRS

audit (.19) -

Pro forma as if the ICOS acquisition

was completed on January 1, 2007 - (.01)

-------------- -----

Totals $3.85 to $4.00 $3.54 9% to 13%

-------------- -----

The company has also revised other aspects of its previously-issued 2008 full-year financial guidance. These revisions are primarily driven by the continued strength of foreign currencies relative to the U.S. dollar. Stronger foreign currencies result in higher growth rates for the company's sales, for its marketing, selling and administrative expenses and, to a lesser extent, for its research and development expenses. In addition, in the short-term, stronger foreign currencies result in a decrease to the company's gross margin as a percent of sales.

Pro forma sales are now expected to grow in the high-single to low-double digits, an increase from the previous guidance of growth in the mid- to high- single digits. Excluding the impact of the second-quarter 2008 asset impairment charges, the company still expects modest improvement in gross margin as a percent of
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Lilly to Acquire SGX Pharmaceuticals
2. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
3. Lilly Employees from Nearly 50 Nations Participate in Companys First-Ever Global Day of Service
4. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
5. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
6. Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
7. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
8. Lilly Reports Solid First-Quarter Results
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
11. Lilly Announces Termination of AIR Insulin Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... company that develops and commercializes proprietary technologies and products ... operational results for the second fiscal quarter ended March ... Company continued to advance business with our existing customers ... , President and CEO of SQI. "The delivery of ...
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)... Worms, Germany (PRWEB) May 21, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACTâ„¢, an independent subsidiary of the International Pharmaceutical ... three Grace facilities that produce its SYLOID® FP ... now received GMP certification, following the Curtis Bay, ...
(Date:5/21/2015)... , May 20, 2015 Research and ... the addition of the "2015 Global Survey ... their offering. The primary goal of ... flow cytometry instruments and reagents. Key information the ... the selection of flow cytometers, predominantly used applications ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2
... Researchers and forensic agencies that test samples or screen post ... suffer from a number of limitations: , They ... commonly available for novel sample matrices such as saliva as they are for urine or ... costly due to the high volume of reagents used. , ...
... Introduction , ... of studying human gene activity and thereby providing insight ... developed the Expression Array System, a complete system for ... (utilizing fully curated transcript data for array design), the ...
... Furazolidone, Furaltadone, Nitrofurazone and Nitrofurantoine belong to the ... treatment of gastrointestinal infections in cattle and poultry. Due ... for furazolidone) was prohibited in 1993 in the European ... 1995 in the European animal breeding (VO (EWG) No. ...
Cached Biology Technology:Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 2Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 4 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 2 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 3 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 4 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 5 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 6 Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data 7Detection of nitrofurane metabolites in food with HPLC/MS/MS 2
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/17/2015)... , April 17, 2015 ... security concerns, and technological advancement to drive biometric ... until 2020   According to ... Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market ... projected to register growth at CAGR of over ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... coaches law enforcement agents, supports CFCE training by ... providing volunteer coaching, ... today that it will be lending Ed Moore, one of,its examiners, ... Examiners (CFCE). Moore, a forensic examiner,that has been with the CCF ...
... Scientists at the University of Amsterdam have discovered how ... lies at the molecular level. The story of ... means for combating other plant diseases, is published May ... and fellow agriculturalists are continuously battling the ability of ...
... doubt about it ... the platypus is one odd ... to fit its aquatic lifestyle and the poison spurs ... patchwork of evolutionary development. But LSUs Mark Batzer, along ... Warren at Washington University in Saint Louis, Mo., has ...
Cached Biology News:Center for Computer Forensics Offers Expert to Volunteer as CFCE Certification Applicants Coach 2First analysis of platypus genome may impact disease prevention 2
... The TOPO Cloning Kits for Sequencing allow ... The kits contain TOPO Cloning vectors with primer ... from the PCR product insertion site. This minimizes ... be read before reaching the sequence of your ...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Zebrafish Vitellogenin ELISA System, 96 wells. ELISARange: 0.5-100 ng/ml.Sensitivity: 0.3 ng/ml.Sample volume: 100 ul.Suitable for use with Zebrafish plasma samples.3-h protocol.Store at 2-8 C. Categ...
Quartz-Halogen, 100 W, High Intensity...
Biology Products: